Business Description
TNF Pharmaceuticals Inc
NAICS : 541713
SIC : 2833
ISIN : US62856X1028
Share Class Description:
TNFA: Ordinary SharesDescription
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 591.22 | |||||
| Equity-to-Asset | 0.71 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.6 | |||||
| 3-Year EPS without NRI Growth Rate | -19.4 | |||||
| 3-Year FCF Growth Rate | -30.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.41 | |||||
| 9-Day RSI | 36.73 | |||||
| 14-Day RSI | 39.27 | |||||
| 6-1 Month Momentum % | -16.25 | |||||
| 12-1 Month Momentum % | -81.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.72 | |||||
| Quick Ratio | 1.72 | |||||
| Cash Ratio | 1.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.7 | |||||
| Shareholder Yield % | 2.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -209.15 | |||||
| ROA % | -113.08 | |||||
| ROIC % | -86.25 | |||||
| ROC (Joel Greenblatt) % | -26223.5 | |||||
| ROCE % | -73.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.17 | |||||
| Price-to-Tangible-Book | 0.47 | |||||
| EV-to-EBIT | 0.62 | |||||
| EV-to-EBITDA | 0.62 | |||||
| EV-to-FCF | 0.69 | |||||
| Price-to-Net-Current-Asset-Value | 0.62 | |||||
| Price-to-Net-Cash | 0.78 | |||||
| Earnings Yield (Greenblatt) % | 161.29 | |||||
| FCF Yield % | -317.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TNFA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TNF Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -13.84 | ||
| Beta | 2.59 | ||
| Volatility % | 73.49 | ||
| 14-Day RSI | 39.27 | ||
| 14-Day ATR ($) | 0.153403 | ||
| 20-Day SMA ($) | 1.300175 | ||
| 12-1 Month Momentum % | -81.63 | ||
| 52-Week Range ($) | 1.12 - 10.665 | ||
| Shares Outstanding (Mil) | 2.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TNF Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TNF Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
TNF Pharmaceuticals Inc Frequently Asked Questions
What is TNF Pharmaceuticals Inc(TNFA)'s stock price today?
The current price of TNFA is $1.16. The 52 week high of TNFA is $10.67 and 52 week low is $1.12.
When is next earnings date of TNF Pharmaceuticals Inc(TNFA)?
The next earnings date of TNF Pharmaceuticals Inc(TNFA) is 2025-02-14 Est..
Does TNF Pharmaceuticals Inc(TNFA) pay dividends? If so, how much?
TNF Pharmaceuticals Inc(TNFA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers